Rising Incidence Of Heart Diseases Fuels Growth In The Implantable Cardiac Devices Market: Powering Innovation and Expansion in the Implantable Cardiac Devices Market by 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_
_x000D_
What Is the Expected CAGR for the Implantable Cardiac Devices Market Through 2025?_x000D_
In recent times, the market size for implantable cardiac devices has seen robust growth. It's projected that the market will expand from $12.34 billion in 2024 to $13.46 billion in 2025, with a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this growth during the historical period include medical technology advancements, an increase in cardiovascular disease cases, a growing older population, enhancements in device dependability and lifespan, increased awareness, and early detection of heart conditions._x000D_
_x000D_
What's the Projected Size of the Global Implantable Cardiac Devices Market by 2029?_x000D_
The market size for implantable cardiac devices is anticipated to experience significant growth in the ensuing years. It is projected to reach a value of $18.81 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.7%. This growth during the forecast period is primarily due to advancements in device technology, a rise in demand for minimally invasive procedures, an increase in the elderly population, higher healthcare spending, and the growth of healthcare infrastructure in developing markets. Major trends expected during this period include the fusion of digital health and remote monitoring, the creation of next-generation devices with improved features, an increase in personalized and patient-specific cardiac treatments, a focus on cost-efficiency and value-based healthcare, a greater emphasis on preventative cardiology, and earlier intervention._x000D_
_x000D_
View the full report here: _x000D_
https://www.thebusinessresearchcompany.com/report/implantable-cardiac-devices-global-market-report_x000D_
_x000D_
Top Growth Drivers in the Implantable Cardiac Devices Industry: What's Accelerating the Market? _x000D_
The surge in heart diseases is anticipated to boost the expansion of the market for implantable cardiac devices. The increment in heart-related diseases can be linked to the growing number of risk factors such as unhealthy diet, lack of physical activity, obesity, and chronic conditions like diabetes and hypertension. Furthermore, older populations and increased stress levels also add to the cases of cardiovascular ailments. Implantable cardiac devices are deployed to manage and treat conditions like heart failure, arrhythmias, and coronary artery disease. This growing requirement propels innovation and investment in the creation of new and enhanced cardiac devices to cater to the enlarging patient community and improve therapeutic results. For instance, as per the data provided by the Singapore Heart Foundation (SHF), a non-profit organization located in Singapore, in May 2024, ischemic heart disease caused 5,302 fatalities, demonstrating a slight increment from 5,290 deaths in 2022. Hence, the surging incidence of heart disease propels the expansion of the market for implantable cardiac devices._x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=19097&type=smp_x000D_
_x000D_
What Trends Will Shape the Implantable Cardiac Devices Market Through 2029 and Beyond?_x000D_
Leading entities in the implantable cardiac devices market are prioritizing enhancements in compatibility with diagnostic tools like AutoMRI, to prolong the lifespan of devices and enhance patient safety. The inclusion of AutoMRI in implantable cardiac defibrillators tailors device settings for safe operation during MRI scans, this not only improves patient care but also provides access to superior imaging technology. An example of this is MicroPort CRM, a medical device firm based in France, which introduced the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan in October 2023. These devices, characterized by advanced technology, low power consumption, extended lifespan, and MRI compatibility, mark key developments in the market. Specifically, the ULYS ICD is equipped with the PARAD+ arrhythmia discrimination algorithm and AutoMRI features, while the INVICTA lead ensures precise pacing and defibrillation therapy. The successful implantation and complication-free rates of these devices in clinical trials were 100% and 97.4%, respectively._x000D_
_x000D_
What Are the Main Segments in the Implantable Cardiac Devices Market?_x000D_
The implantable cardiac devicesmarket covered in this report is segmented - _x000D_
_x000D_
1) By Type: Pacemaker, Implantable Cardioverter Defibrillator (ICD), Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)_x000D_
2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications_x000D_
3) By End User: Hospitals, Specialty Clinics, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Pacemaker: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Rate-Responsive Pacemakers_x000D_
2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs, Subcutaneous ICDs, Wearable Cardioverter Defibrillators_x000D_
3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs, Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)_x000D_
_x000D_
Tailor your insights and customize the full report here:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=19097&type=smp_x000D_
_x000D_
Which Top Companies are Driving Growth in the Implantable Cardiac Devices Market?_x000D_
Major companies operating in the implantable cardiac devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Berlin Heart GmbH, EBR Systems Inc., Defibtech LLC, CVRx Inc., Progetti Srl, Endotronix Inc., Jarvik Heart Inc., Xeltis AG, Carmat SA, Windmill Cardiovascular Systems Inc _x000D_
_x000D_
Which Regions Will Dominate the Implantable Cardiac Devices Market Through 2029?_x000D_
North America was the largest region in the implantable cardiac devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
Purchase the full report today:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19097_x000D_
_x000D_
"This Report Supports:_x000D_
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions._x000D_
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning._x000D_
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks._x000D_
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.